Debt-to-equity of Definium Therapeutics, Inc. from 30 Sep 2022 to 31 Dec 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Definium Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2022 to 31 Dec 2025.
Definium Therapeutics, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 40%, a 36% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Definium Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q4 2025	40%	+10%	+36%	31 Dec 2025
Q3 2025	38%	+4.6%	+13%	30 Sep 2025
Q2 2025	27%	-14%	-34%	30 Jun 2025
Q1 2025	26%	-18%	-41%	31 Mar 2025
Q4 2024	29%	-8.1%	-22%	31 Dec 2024
Q3 2024	34%	+7.7%	+30%	30 Sep 2024
Q2 2024	42%	+22%	+108%	30 Jun 2024
Q1 2024	44%	+29%	+200%	31 Mar 2024
Q4 2023	37%	+25%	+208%	31 Dec 2023
Q3 2023	26%	+15%	+139%	30 Sep 2023
Q2 2023	20%			30 Jun 2023
Q1 2023	15%			31 Mar 2023
Q4 2022	12%			31 Dec 2022
Q3 2022	11%			30 Sep 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.